Peer-reviewed article
Balloon cells in type II focal cortical dysplasia: developmental origins, molecular signatures, and epileptogenic mechanisms
Yan Gao, Xinna Ji, Shuo Feng, Yanyan Gao, Lingxue Li et al. ·
Summary
Written by AI, not yet AICS's view · claude-sonnet-5-5This review looks at balloon cells, an abnormal cell type found in type II focal cortical dysplasia, a common cause of epilepsy in children that does not respond to drugs. It describes how these cells may arise from disrupted brain development, often linked to somatic mutations in the PI3K-AKT-mTOR pathway. It also covers their molecular features, their largely silent electrical activity, and the abnormal surrounding tissue environment. The authors say the specific role of balloon cells in causing seizures is still unresolved. They suggest that understanding these cells could lead to targeted treatments beyond surgery.
Key points
- Balloon cells are a defining feature of FCD IIb, a major cause of drug-resistant epilepsy in children.
- Somatic mosaic mutations in the PI3K-AKT-mTOR pathway are often linked to balloon cells and their abnormal development.
- Balloon cells are largely electrically silent but sit in tissue with disrupted inhibitory circuits and complement-associated synaptic remodeling.
- Single-cell and spatial transcriptomic studies distinguish balloon cells from dysmorphic neurons and link them to local immune activation.
- The specific causal contribution of balloon cells to seizures remains unresolved.
Limitations
This is a narrative review of cell and tissue biology, not a study of children's well-being, services or interventions. The abstract does not say which country the work is about or give any outcome data for children.
Abstract
Type II focal cortical dysplasia (FCD II) is a major cause of drug-resistant epilepsy in children, with balloon cells representing a defining histopathological feature of FCD IIb. Although diagnostically important, the biological identity and epileptogenic contribution of balloon cells remain incompletely understood. Current evidence links balloon cells to disrupted cortical development, often driven by somatic mosaic mutations in the PI3K-AKT-mTOR pathway, resulting in impaired differentiation, cellular enlargement, and hybrid neuroglial phenotypes. This review examines current evidence on the developmental origins and lineage states, molecular signatures, electrophysiological features, and network effects of balloon cells in FCD II. Persistent mTOR hyperactivation appears to interact with cytoskeletal abnormalities, oxidative stress, and local inflammatory signaling, thereby creating a microenvironment that favors epileptogenic remodeling. Despite being largely electrically silent, BCs are embedded within lesion microenvironments characterized by disrupted inhibitory circuitry, altered neurotransmitter homeostasis, and complement-associated synaptic remodeling. BCs may participate indirectly in these processes, although their cell-specific causal contribution remains unresolved. Recent single-cell and spatial transcriptomic studies further distinguish balloon cells from dysmorphic neurons and implicate them in local immune activation. Understanding balloon cell biology may reveal cell-specific therapeutic targets and support precision treatment strategies beyond surgical resection.